Physician profile
Michael Ryan Sweeney
NPI 1619556461
$7,881.61
in general payments reported to CMS, 2019-2025
12 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $6,876 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,886 · Food and Beverage: $2,838 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,886.45 |
| Food and Beverage | $2,837.68 |
| Education | $157.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $4,033.42 | 2024 | Truelok |
| Stryker Corporation | $2,560.40 | 2024-2025 | Ortholoc 3di, Inspace, Allofiber |
| Abbott Laboratories | $240.46 | 2025 | Esprit |
| Vilex LLC | $210.51 | 2025 | Dynex |
| Treace Medical Concepts, INC. | $197.64 | 2025 | |
| Bioventus LLC | $146.87 | 2024 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $110.02 | 2024 | Krystexxa |
| Polynovo North America LLC | $107.28 | 2024 | Novosorb Btm |
| Abbvie INC. | $106.57 | 2024 | |
| Paragon 28, INC. | $97.22 | 2025 | Phantom Fibula Nail, Precision Mis Bunion |
| Smith+Nephew, INC. | $56.22 | 2024 | Renasys Touch |
| Alpha Orthopedic Systems | $15.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.